These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30284714)

  • 1. Peri-anaesthetic cardiac arrest with administration of enalapril, spironolactone and β-blocker.
    Basquin C; Simeon C; Gentili ME
    Anaesthesiol Intensive Ther; 2018; 50(4):323. PubMed ID: 30284714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiogram changes in hyperkalemia: there and back again.
    Zimlichman E; Liran O
    Isr Med Assoc J; 2005 Nov; 7(11):748. PubMed ID: 16309005
    [No Abstract]   [Full Text] [Related]  

  • 3. Normal ECG or peaked T waves?
    Hancock EW
    Hosp Pract (1995); 1998 May; 33(5):19-20. PubMed ID: 9606350
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Junctional escape rhythm secondary to acute hyperkalemic renal failure in the setting of concurrent beta-blocker therapy.
    Isabel J; Champion JC
    JAAPA; 2006 Dec; 19(12):78. PubMed ID: 17243264
    [No Abstract]   [Full Text] [Related]  

  • 6. Serious adverse events experienced by patients with chronic heart failure taking spironolactone.
    Berry C; McMurray JJ
    Heart; 2001 Apr; 85(4):E8. PubMed ID: 11250985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E
    Internist (Berl); 2005 Apr; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract]   [Full Text] [Related]  

  • 8. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
    Juurlink DN; Mamdani MM; Lee DS; Kopp A; Austin PC; Laupacis A; Redelmeier DA
    N Engl J Med; 2004 Aug; 351(6):543-51. PubMed ID: 15295047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe complications during enalapril therapy for heart insufficiency].
    Wieland T; Stäubli M
    Schweiz Med Wochenschr; 1988 Dec; 118(48):1789-92. PubMed ID: 2849806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.
    Williams GH; Burgess E; Kolloch RE; Ruilope LM; Niegowska J; Kipnes MS; Roniker B; Patrick JL; Krause SL
    Am J Cardiol; 2004 Apr; 93(8):990-6. PubMed ID: 15081441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [When the tongue impairs breathing].
    Lorez A; Scholz S; Kohler HP; Nohl F
    Praxis (Bern 1994); 2005 Dec; 94(49):1963-6. PubMed ID: 16416930
    [No Abstract]   [Full Text] [Related]  

  • 13. Sinus arrest and moderate hyperkalemia.
    Bonvini RF; Hendiri T; Anwar A
    Ann Cardiol Angeiol (Paris); 2006 Jun; 55(3):161-3. PubMed ID: 16792034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
    Wrenger E; Müller R; Moesenthin M; Welte T; Frölich JC; Neumann KH
    BMJ; 2003 Jul; 327(7407):147-9. PubMed ID: 12869459
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ineffective atrial pacing and cardiac arrest in a 80-year old woman with hyperkalemia].
    Lelakowski J; Czunko A; Majewski J; Pasowicz M; Małecka B; Bednarek J
    Pol Merkur Lekarski; 2005 May; 18(107):566-7. PubMed ID: 16161957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a simultaneous beta-blocker therapy a risk factor for enalapril-induced cough?
    Puolijoki HJ; Nieminen MM; Siitonen LO; Lahdensuo AH; Reinikainen PM
    Respiration; 1989; 55(2):127-8. PubMed ID: 2570450
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations.
    Johnston RT; de Bono DP; Nyman CR
    Int J Cardiol; 1992 Feb; 34(2):213-5. PubMed ID: 1737674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I; Hotnes T; Dollerup J; Mogensen CE
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of hyperkalemia risk after hypertension control with aldosterone blockade according to the presence or absence of chronic kidney disease.
    Gwoo S; Kim YN; Shin HS; Jung YS; Rim H
    Nephron Clin Pract; 2014; 128(3-4):381-6. PubMed ID: 25572273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute reversible kidney insufficiency due to enalapril during diuretic-treated heart insufficiency].
    Degenhardt S
    Dtsch Med Wochenschr; 1987 Jun; 112(24):960-3. PubMed ID: 3036457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.